Sciences of Pharmacy
Open Access Journal

Sciences of Pharmacy

p-ISSN: 2830-7046
e-ISSN: 2830-7259
DOI: 10.58920/sciphar
sciphar@etflin.com (Managing Editor)
Preclinical and clinical drug developmentDrug deliveryPharmaceutical formulationPharmacodynamicsPharmacokineticsDrug metabolismPharmacogeneticsGene-based therapyCell-based therapyProtein-based therapyDrug classesDrug nomenclatureDrug-drug interactionAdverse drug reactionDrug toxicityPharmacovigilancePharmacoepidemiologyPharmacoeconomicsClinical pharmacy

Official Affiliation

Affiliation logo

Volume 2 Issue 3

Showing 9 Articles

RESEARCH ARTICLE

  • Psychotropic Drugs Used in Psychiatry Outpatient Department: A Cross-Sectional Drug Utilization Research
    research article

    Psychotropic Drugs Used in Psychiatry Outpatient Department: A Cross-Sectional Drug Utilization Research

    Hiteswar Saikia, Mustakim Ahmed, Anju L. Saikia, Daisy Phukan

    Mental and behavioral disorders are common around the world. Pharmacotherapy, psychotherapy, and psychosocial rehabilitation are three treatment components for these disorders. Drug therapy is an essential part of the comprehensive treatment of these diseases. Their use pattern in psychiatric practice has changed dramatically in recent years. Mental disorders require long-term treatment. Therefore, it is crucial to study the prescribing practices of these groups of drugs. This study aims to assess drug use patterns using the WHO/INRUD Core Prescribing Indicators. Patients of both genders and ages with mental illness and prescription psychiatric drugs were evaluated from the outpatient department of the Psychiatry Unit (OPD). The prescription data were collected and analyzed using the indicators recommended by the WHO/INRUD. The data were analyzed using Microsoft Excel-2007. The percentage and average values of the variables were compared. A total of 655 prescriptions were analyzed. Male patients (54.96%) were more than women (45.04%). The morbidity profile included schizophrenia (37.86%), alcohol use disorder (18.78%), major depressive disorder (11.30%), anxiety disorder (10.23%), bipolar disorder (4.88%), and others (16.95%). The newer antipsychotic were the most commonly prescribed drugs (particularly olanzapine), along with a central anticholinergic (trihexyphenidyl) and a benzodiazepine (lorazepam). The percentage of drugs prescribed with generic names was 39.80%, and that of drugs prescribed by NLEM was 48.49%. The average number of drugs prescribed per prescription was 2.58. This study's Index of Rational Prescribing (IRDP) was 3.87, whereas the optimal score was 5. Prescriptions were complete, and principles of rational prescribing were followed, except for a low generic prescribing rate.

    Sciences of Pharmacy

    6 Jul 2023
    10 pages
  • Phytochemical Analysis, In-vitro, and In-silico Antibacterial Activity of Stembark Extract of Anogeissus leiocarpus (DC) Guill and Perr
    research article

    Phytochemical Analysis, In-vitro, and In-silico Antibacterial Activity of Stembark Extract of Anogeissus leiocarpus (DC) Guill and Perr

    Mubarak Muhammad Dahiru, AbdulAzeez Mumsiri Abaka, Neksumi Musa

    Bacterial infections subsequently leading to antibiotic resistance has been a leading cause of mortality and morbidity worldwide especially in developing countries with high poverty rate and poor healthcare system. Thus, prompting the prospect in alternative therapy such as medicinal plants. In the present study, we evaluated the antibacterial action of stem bark extract of Anogeissus leiocarpus (AL) Guill and Perr. as applied in folkloric medicine for antibacterial purposes. The phytochemicals present in the plant extract were identified and quantified, followed by the determination of the antibacterial effects of the extract against Escherichia coli and Staphylococcus aureus. Molecular docking study was carried out to ascertain the inhibitory effects of compounds from AL against bacterial enzymes. Alkaloids (7.17% ±0.60), saponins (11.33% ±3.18), and flavonoids (31.01% ±4.04) were detected. A maximum ZI was observed for E. coli compared to S. aureus at the highest extract concentration (100 mg/mL) with amoxicillin having superior ZI at 50 mg/mL concentration. The MIC against E. coli and S. aureus were 12.5 mg/mL and ≤ 6.25 mg/mL respectively while the MBC was>100 mg/mL and 100 mg/mL respectively. Among the identified compounds, IX exhibited the least binding affinity (BA) (7.2 kcal/mol) and inhibition constant (Ki) (5 µM) against UDP-N-acetylglucosamine Enolpyruvyl Transferase (Mur A) compared to all the other targets. AL demonstrated antibacterial activity evidenced by the bacterial growth inhibition, bactericidal potential, and in-silico study revealing high affinity of the bacterial enzymes for the identified compounds, thereby supporting the acclaimed antibacterial use of the plant in folkloric medicine.

    Sciences of Pharmacy

    5 Jun 2023
    14 pages
  • research article

    Exploring the Antiepileptic Potential of Amaranthus spinosus: An Experimental Study in Albino Mice

    Mus'ab Usman Abba, Sunusi Usman, Muslim Muhammad Ahmad, Albashir Tahir, Aminu Kura Umar

    About 60% of the world population relies on herbal medicine, and 80% depend almost entirely on it for their primary healthcare. Many of these herbs are rich in phytochemicals, thus valuable as potential sources of drugs. Amaranthus spinosus is a vegetable and ornamental plant used in African folklore to treat several illnesses. This study aimed to investigate the antiepileptic potential of the methanol leaf extract of Amaranthus spinosus in albino mice. Preliminary phytochemical screening and acute toxicity studies were conducted using standard methods. Anticonvulsant studies were conducted using chemo-shock models (pentylenetetrazole (PTZ) - and strychnine (STR)-induced seizures) in mice. Phytochemical screening has revealed the presence of terpenoids, tannins, saponins, alkaloids, anthraquinones, carbohydrates, cardiac glycosides, and flavonoids. Additionally, the acute toxicity studies of the extract revealed that the extract is safe in mice at 2000 mg/kg. The extract at 400 and 800 mg/kg produced a significant (p<0.05) delay in the mean onset of seizures, decreased the duration of seizures induced by PTZ in a dose-dependent manner, and protected the mice. The extract showed insignificant protection against strychnine-induced seizures in mice. This could serve as a scientific basis for further evaluation of the plant’s potential in managing epilepsy, which can lead to the discovery of an effective antiepileptic agent with fewer side effects.

    Sciences of Pharmacy

    5 Aug 2023
    7 pages
  • Quality Control of Herbal Drug (Paxherbal Bitter Tea) Via Thin-Layer Chromatography and Phytoconstituent Analysis
    research article

    Quality Control of Herbal Drug (Paxherbal Bitter Tea) Via Thin-Layer Chromatography and Phytoconstituent Analysis

    Tunde Ayobami Owolabi, Emmanuel Amodu, James Danga

    The effectiveness of any herbal medication depends on the presence or absence of pharmacologically active phytocompounds. These ingredients are significantly affected by the quality control system espoused during and after manufacturing processes and the operation of such pharmaceuticals. Thin-layer chromatography (TLC) is a quality control parameter suitable to identify and codify substances predicated on their distinctiveness and uniformity, giving an identity for such substances. Paxherbal Bitter Tea is a polyherbal medicine harnessed as an anti-diabetes medicine. This study assessed the distinguishable phytoconstituents present and evolved attribute profiles (TLC) for the herbal (Paxherbal Bitter Tea) to serve as a quality control check during manufacturing for consistency and market identity. Qualitative phytochemical and chromatographic assays were carried out employing standard methodologies. The qualitative test revealed the presence of saponin, steroids, reducing sugar, cardiac glycoside, and terpenoids, and the finger-print chromatograms after progression with n-hexane: ethyl acetate (9:1) flaunted three dissimilar elements under ultraviolet light at 365 nm and five spots, when dotted with 20% methanolic sulphuric acid under visible light. In this study, we developed an identity profile for Paxherbal Bitter Tea via its unique chemical biographies, which can be exercised in verifying the quality and consistency of the herbal product.

    Sciences of Pharmacy

    28 Aug 2023
    5 pages
  • Efficacy of Sunscreen Gel Infused with Giant Tiger Prawn (Penaeus monodon) Head Extract
    research article

    Efficacy of Sunscreen Gel Infused with Giant Tiger Prawn (Penaeus monodon) Head Extract

    Adilah Marwa, Nuraini Ekawati, Hardian Hardian

    Excessive sunlight exposure can lead to various minor skin disorders, including sunburn and the development of chronic skin malignancies. One effective preventive measure against these adverse effects is the use of sunscreen. Sunscreen can be derived from natural sources, such as the astaxanthin compound in giant tiger prawns (Penaeus monodon). This study aimed to formulate a sunscreen gel from giant tiger prawn head extract that meets good physical gel standards. Additionally, the study sought to determine the sun protection factor (SPF), erythema transmission level (%TE), and pigmentation transmission level (%TP) through in-vitro testing. The extraction process involved using coconut oil as a solvent using the maceration method. The resultant extract was then evaluated for SPF, %TE, and %TP values and subsequently formulated into gel variants with extract concentrations ranging from 1% to 10%. The findings of this investigation revealed that the giant tiger prawn head extract exhibited SPF, %TE, and %TP values of 8.0 ± 0.11, 18.8 ± 0.25%, and 21.7 ± 0.73%, respectively, categorizing it as providing maximum protection, facilitating fast tanning, and acting as a sunblock. The gel formula containing 8% giant tiger prawn head extract demonstrated the highest sunscreen potential. In conclusion, this study highlights the promising potential of giant tiger prawn head extract as a natural sunscreen ingredient and identifies the optimal gel formula for effective sun protection.

    Sciences of Pharmacy

    5 Sept 2023
    13 pages

REVIEW

  • Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?
    review

    Chatbots in Pharmacy: A Boon or a Bane for Patient Care and Pharmacy Practice?

    Chusnul Nur Ramadhani

    Chatbots in pharmacies have gained popularity in recent years, potentially revolutionizing patient care and pharmacist workflow. However, whether chatbots are, a boon or a bane for the pharmacy profession remains. This review article aims to comprehensively analyze the literature on chatbots in pharmacy, including their benefits, limitations, and future directions. Findings suggest that chatbots have the potential to improve medication adherence, provide patient education, and streamline pharmacist workflow. However, there are limitations to their use, such as the need for robust natural language processing algorithms and concerns regarding patient privacy and security. Furthermore, the lack of regulatory oversight and standardized development processes may hinder their widespread adoption. Overall, while chatbots have the potential to improve certain aspects of pharmacy practice, caution must be taken to ensure their accuracy and safety. Moreover, chatbots should be viewed as a tool to support pharmacists in providing high-quality patient care rather than replacing the valuable expertise and human connection pharmacists provide. Further research is needed to explore the full potential of chatbots in pharmacy practice and to address the limitations and concerns highlighted in this review.

    Sciences of Pharmacy

    3 Jul 2023
    17 pages
  • Phytochemicals Modify the Action of Cancer Cells Mitochondrial Drug-Resistance Mechanism
    review

    Phytochemicals Modify the Action of Cancer Cells Mitochondrial Drug-Resistance Mechanism

    Subha Ranjan Das

    The genesis and evolution of cancer are known to be significantly influenced by mitochondria, and recent studies have indicated that mitochondrial modifications may potentially contribute to the emergence of treatment resistance. Additionally, drug-resistant cancer cells may also display modifications in mitochondrial metabolism, such as changes in the generation of reactive oxygen species (ROS), which are biological byproducts of mitochondrial respiration. These changes can alter the cell's sensitivity to chemotherapy drugs and contribute to drug resistance. The expression of specific genes or proteins that are crucial in the control of cell growth and survival may be altered by mitochondrial mutations, which may also contribute to medication resistance. Phytochemicals are naturally occurring, biologically active substances found in plants that have been demonstrated to offer a variety of health advantages, including anti-cancer effects. It has been demonstrated that phytochemicals target these altered mitochondrial pathways in cancer cells, increasing the potency of chemotherapy medications and overcoming drug resistance. For instance, it has been demonstrated that some phytochemicals, including curcumin, resveratrol, and quercetin, can block the function of mitochondrial membrane proteins that lead to drug resistance in cancer cells. Other phytochemicals, including berberine and epigallocatechin gallate (EGCG), have been demonstrated to directly interfere with mitochondrial activity, inducing apoptosis (programmed cell death) in cancer cells. Overall, the capacity of phytochemicals to modify the functioning of cancer cell mitochondrial drug-resistance systems is a viable strategy for the creation of novel anti-cancer treatments.

    Sciences of Pharmacy

    14 Jul 2023
    20 pages
  • Comparison of Microsampling and Conventional Sampling Techniques for Quantification of Warfarin in Blood Samples: A Systematic Review
    review

    Comparison of Microsampling and Conventional Sampling Techniques for Quantification of Warfarin in Blood Samples: A Systematic Review

    Callista Andinie Mulyadi, Yahdiana Harahap, Hary Sakti Muliawan

    Warfarin is a vitamin K antagonist (VKAs) anticoagulant associated with interindividual patients’ response to therapy, narrow therapeutic index, and serious adverse drug events. Monitoring ensures efficacy and safety by measuring drug concentration in the bloodstream, which demands blood or plasma samples from patients through conventional sampling. Conventional sampling often requires invasive methods that may be uncomfortable for patients. Microsampling offers an opportunity to reduce the burden of multiple blood sampling on patients and simplifies the process of sample transportation and storage. This systematic review describes conventional and microsampling techniques for quantifying warfarin in human blood samples and the bioanalytical method employed to perform the analysis. Related studies (537) were screened from several databases and narrowed down into 12 eligible articles, which were then used to fulfill the purpose of this review in a narrative form. It is concluded that while there are still limited studies regarding the application of microsampling for warfarin quantification in patients, there has been evidence of comparable plasma and micro samples results, highlighting the potential for future development of routine monitoring using the microsampling technique.

    Sciences of Pharmacy

    6 Jul 2023
    13 pages
  • In Silico Studies of Drug Discovery and Design Against COVID-19 Focusing on ACE2 and Spike Protein Virus Receptors: A Systematic Review
    review

    In Silico Studies of Drug Discovery and Design Against COVID-19 Focusing on ACE2 and Spike Protein Virus Receptors: A Systematic Review

    Matheus prayoga claus, Masteria Yunovilsa Putra, Arry Yanuar

    The emergence of COVID-19 has prompted researchers worldwide to focus on developing drugs that specifically target ACE2 receptors and SARS-CoV-2 Spike Protein receptors. They have embraced an in-silico approach that employs virtual screening, molecular docking, and molecular dynamics to achieve this. This innovative method harnesses existing chemical and natural product databases to identify the most suitable ACE2 receptor blockers and SARS-CoV-2 Spike Protein inhibitors. By following the PRISMA statement guidelines, a thorough literature search yielded 21 relevant articles, forming the basis of this systematic review. The review provides a comprehensive summary and detailed description of the methodologies, protocols, software tools, and noteworthy drug candidates identified in these studies. Additionally, it sheds light on the crucial molecular interactions by presenting an overview of the interacting residues elucidated in the reviewed articles, offering valuable insights for effective therapeutic interventions. Furthermore, the review presents thought-provoking suggestions for future research directions, aiming to inspire and guide advancements in drug development efforts.

    Sciences of Pharmacy

    6 Jul 2023
    13 pages

Journal Key Facts

Publishing Fee (APC)

IDR 1,100,000

Open Access License

CC BY 4.0

Language

English

Abstracting & Indexing
SintaCAS

Overview

Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy published by ETFLIN. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. SciPhar accepts original article, reviews, mini-review, book-review, technical note, case report, case series, clinical trial, opinion/perspective, conference proceeding, and pictorial essay. Author may submit or suggest another type of scientific manuscript. Sciphar publishes 4 issues a year. Sciences of Pharmacy is affiliated with Faculty of Pharmacy, Universitas Islam Sultan Agung.

Current Issue

Latest Articles

Recently published research articles, review papers, and technical notes from the current volume of the journal.

  • review

    Genetic Polymorphism of N-acetyltransferase 2 (NAT2) among Patients with Tuberculosis: A Scoping Review of the Indonesian Studies

    Oki Nugraha Putra, Sylvia Rizki Ramadhani, Yulistiani Yulistiani, Julaeha Julaeha, Affan Yuniar Nur Hidayatullah

    The distribution of N-acetyltransferase-2 (NAT2) genetic polymorphisms varies across ethnic groups among Indonesian TB patients. This review aimed to provide a comprehensive understanding of the prevalence of NAT2 genetic polymorphisms and their association with DILI and isoniazid pharmacokinetics in Indonesian TB patients. A scoping review was conducted by searching Google Scholar, Scopus, and PubMed in accordance with PRISMA guidelines for scoping review (PRISMA-ScR). We retrieved 668 studies from three databases and we enrolled 12 studies for final analysis. Eleven studies reported on adult TB patients and one study on pediatric TB patients. Overall, the available evidence suggests that the slow acetylator phenotype is relatively common among TB patients in Indonesia, although its distribution varies across regions and ethnic groups. The NAT2*6 polymorphism was frequently observed among TB patients with a slow acetylator phenotype. TB patients with slow acetylation exhibited higher serum concentrations of isoniazid, which were significantly associated with an increased risk of DILI. No studies reported an association between NAT2 genetic polymorphisms or acetylation status and treatment outcomes among TB patients. This review confirms substantial variation in NAT2 genetic polymorphisms across studies in Indonesia. TB patients with a slow acetylator phenotype appear to have a greater risk of developing DILI compared with those with intermediate or fast acetylator phenotypes.  Information on acetylator status may identify patients at higher risk of hepatotoxicity, particularly those with the slow acetylator phenotype. Therefore, integrating NAT2 pharmacogenetics into clinical practice may predict hepatotoxicity and optimize tuberculosis therapy.

    Sciences of Pharmacy

    21 Apr 2026
    9 pages
  • research article

    Green-Synthesized Silver Nanoparticles Using Erythrina subumbrans Leaf Extract: Optimization and Antibacterial Activity

    Indri Maharini, Karen Putri Utami, Lilis Rachmawati, Fitrianingsih Fitrianingsih, Puspa Dwi Pratiwi

    The high prevalence of acne and increasing antibiotic resistance necessitate the development of sustainable antimicrobial agents. This study investigated the green synthesis of silver nanoparticles (AgNPs) using Erythrina subumbrans (Hassk.) Merr. leaf extract as a natural bioreductant and stabilizer. The primary objective was to optimize the synthesis process and evaluate the antibacterial efficacy of the resulting nanoparticles specifically against Propionibacterium acnes. Physicochemical and structural characterization were performed using spectroscopic and microscopic techniques to confirm the formation and stability of the nanoparticles. The results successfully demonstrated the synthesis of crystalline, nanoscale AgNPs with plant-derived functional groups facilitating their stabilization. Analytical data indicated a relatively uniform particle size distribution, spherical morphology, and favorable surface characteristics, suggesting high suitability for biomedical integration. Significantly, the synthesized AgNPs exhibited potent antibacterial activity against P. acnes. The underlying mechanism of action is attributed to the disruption of bacterial cell membranes, induction of intracellular reactive oxygen species, and subsequent interference with vital cellular functions. Utilizing E. subumbrans extract offers an eco-friendly, cost-effective, and sustainable alternative to conventional chemical synthesis, reducing the reliance on toxic reagents. These findings highlight the significant potential of plant-mediated AgNPs as innovative antimicrobial agents for dermatological applications. This research provides a robust foundation for the advancement of nanotechnology-based topical treatments. Consequently, further investigation into pharmaceutical formulation development, comprehensive safety assessments, and clinical efficacy trials is highly recommended to establish E. subumbrans-mediated silver nanoparticles as viable therapeutic solutions for managing acne and other skin-related infections in the future.

    Sciences of Pharmacy

    21 Apr 2026
    11 pages
  • research article

    Physico-Chemical Characterisation and Determination of Luteolin Content of Red Pidada (Sonneratia Caseolaris L.) Leaf Extract

    Eka Siswanto Syamsul, Dwi Lestari, Dachriyanus Dachriyanus, Supomo Supomo

    Red Pidada (Sonneratia caseolaris L.) leaves are widely used in traditional medicine, particularly for skin care and treatment of minor ailments. This study aimed to characterise the powdered leaf material and determine luteolin content of the ethanolic leaf extract. Dried leaf powder was extracted by maceration using ethanol. The powdered material was characterised through macroscopic and microscopic evaluations, as well as determining physicochemical parameters including water-soluble extractive value, ethanol-soluble extractive value, moisture content, total ash, and acid-insoluble ash. Furthermore, metabolite profiling of the extract was conducted using high-resolution liquid chromatography–mass spectrometry (HR-LCMS) to identify constituents. Luteolin content was quantified using thin-layer chromatography (TLC) densitometry on silica gel 60 F254 plates with a mobile phase of n-hexane:ethyl acetate (2:3). Macroscopically, the leaves were oval to elongated, with rounded to blunt apices, entire margins, pinnate venation, and dark-green colour. Microscopic examination revealed upper and lower epidermal tissues, stomata, and vascular bundles. The powdered leaves exhibited a bitter taste. The water-soluble and ethanol-soluble extractive values were 11% and 16%, respectively, while moisture content, total ash, and acid-insoluble ash were 8.8%, 8.12%, and 0.47%. HR-LCMS analysis produced 38 tentative compound matches, including luteolin. Under specified conditions, TLC-densitometry showed an Rf value of 0.54 for luteolin, with a mean amount of 3.849 µg. These findings provide baseline physicochemical and phytochemical data for standardisation of S. caseolaris L. leaf extract for future research applications and quality control purposes in pharmaceutical and herbal product development to ensure consistency safety and efficacy across batches.

    Sciences of Pharmacy

    28 Apr 2026
    7 pages
  • research article

    Analysis of Psychotropic Drug Utilization in Patients With Organic Mental Disorders

    Yuliawati Yuliawati, Indah Sri Wulan Sofyan, Nurul Kamilah Sadli, Fathnur Sani Kasmadi

    Organic mental disorders are psychiatric conditions caused by identifiable brain pathology or specific systemic diseases, characterized by psychotic, affective, anxiety, and cognitive symptoms that can impair daily functioning. Psychotropic medications play a central role in their management; however, data on utilization patterns, particularly among outpatients in regional psychiatric hospitals, remain limited. This study aimed to quantitatively evaluate the use of psychotropic drugs using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) method recommended by the World Health Organization, and to identify drugs within the Drug Utilization 90% (DU90%) segment to support rational drug use. This retrospective descriptive study utilized secondary data from medical records of outpatients diagnosed with organic mental disorders at Kolonel H. M. Syukur Regional Psychiatric Hospital, Jambi, in 2024, with a total sampling of 100 patients. The results showed that the total psychotropic drug utilization was 9.89 DDD per patient per day. Antipsychotics were the most frequently used class, followed by antidepressants and anxiolytics. The DU90% segment consisted of eleven drugs, predominantly atypical antipsychotics, selective serotonin reuptake inhibitors (SSRIs), and benzodiazepines, with olanzapine, escitalopram, fluoxetine, and alprazolam being the most commonly prescribed. Most patients were male, in the productive age group, and diagnosed with unspecified organic mental disorders. Overall, the pattern of psychotropic drug utilization reflects the complexity of clinical manifestations in organic mental disorders and underscores the importance of monitoring drug use to promote rational prescribing practices in clinical settings.

    Sciences of Pharmacy

    9 Apr 2026
    11 pages
  • review

    Leveraging Artificial Intelligence to Strengthen Vaccine and Drug Development Capacity in Low-resource African Settings

    Courage Chandipwisa, Harrison Banda, Kapembwa Chabala, Tendai Pride Zenda, Agness Shimilimo

    Africa’s vaccine and drug research and development capacity remains limited by infrastructural gaps, fragmented data systems, and shortages of skilled personnel, constraining timely therapeutic discovery and clinical translation in low-resource settings. Artificial intelligence (AI) and machine learning offer potential solutions by enabling predictive modelling, accelerating compound screening, improving genomic surveillance, and supporting adaptive clinical trial design. This narrative review synthesizes studies and institutional reports published between 2015 and 2025 from major scientific databases to examine AI applications in vaccine and drug development relevant to African contexts. Thematic analysis identified key patterns related to infrastructure readiness, workforce capacity, and translational implementation, with findings validated through evidence triangulation and consensus review. Results show that AI platforms have supported infectious disease candidate identification, pandemic vaccine development, malaria drug resistance mapping, and predictive analytics for vaccine distribution. While accelerated outcomes were evident during public health emergencies, routine implementation remains constrained by resource availability. Major challenges include inadequate digital infrastructure, fragmented regulatory systems, and limited technical expertise despite ongoing capacity-building initiatives. The review proposes an integrated framework linking infrastructure, skills development, and ethical governance as critical factors for sustainable AI adoption in African biomedical research. Strengthening investment, fostering regional collaboration, and developing context-specific ethical frameworks are essential to ensure equitable access, enhance innovation capacity, and build resilient biomedical research ecosystems across Africa.

    Sciences of Pharmacy

    28 Apr 2026
    17 pages